114 related articles for article (PubMed ID: 25448846)
1. Regulation of cytokine-inducible SH2-containing protein (CIS) by ubiquitination and Elongin B/C interaction.
Jensik PJ; Arbogast LA
Mol Cell Endocrinol; 2015 Feb; 401():130-41. PubMed ID: 25448846
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase.
Bullock AN; Debreczeni JE; Edwards AM; Sundström M; Knapp S
Proc Natl Acad Sci U S A; 2006 May; 103(20):7637-42. PubMed ID: 16675548
[TBL] [Abstract][Full Text] [Related]
3. Elongin B/C recruitment regulates substrate binding by CIS.
Piessevaux J; De Ceuninck L; Catteeuw D; Peelman F; Tavernier J
J Biol Chem; 2008 Aug; 283(31):21334-46. PubMed ID: 18508766
[TBL] [Abstract][Full Text] [Related]
4. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.
Vesterlund M; Zadjali F; Persson T; Nielsen ML; Kessler BM; Norstedt G; Flores-Morales A
PLoS One; 2011; 6(9):e25358. PubMed ID: 21980433
[TBL] [Abstract][Full Text] [Related]
5. Mammalian protein-protein interaction trap (MAPPIT) analysis of STAT5, CIS, and SOCS2 interactions with the growth hormone receptor.
Uyttendaele I; Lemmens I; Verhee A; De Smet AS; Vandekerckhove J; Lavens D; Peelman F; Tavernier J
Mol Endocrinol; 2007 Nov; 21(11):2821-31. PubMed ID: 17666591
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules.
Chida D; Wakao H; Yoshimura A; Miyajima A
Mol Endocrinol; 1998 Nov; 12(11):1792-806. PubMed ID: 9817603
[TBL] [Abstract][Full Text] [Related]
7. The SOCS box-adapting proteins for ubiquitination and proteasomal degradation.
Linossi EM; Nicholson SE
IUBMB Life; 2012 Apr; 64(4):316-23. PubMed ID: 22362562
[TBL] [Abstract][Full Text] [Related]
8. Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes.
Nie L; Zhao Y; Wu W; Yang YZ; Wang HC; Sun XH
Cell Res; 2011 May; 21(5):754-69. PubMed ID: 21119685
[TBL] [Abstract][Full Text] [Related]
9. In vitro ubiquitination of cytokine signaling components.
Babon JJ; Laktyushin A; Kershaw NJ
Methods Mol Biol; 2013; 967():261-71. PubMed ID: 23296736
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying the diminished sensitivity to prolactin negative feedback during lactation: reduced STAT5 signaling and up-regulation of cytokine-inducible SH2 domain-containing protein (CIS) expression in tuberoinfundibular dopaminergic neurons.
Anderson ST; Barclay JL; Fanning KJ; Kusters DH; Waters MJ; Curlewis JD
Endocrinology; 2006 Mar; 147(3):1195-202. PubMed ID: 16357045
[TBL] [Abstract][Full Text] [Related]
11. Maximal expression of suppressors of cytokine signaling in the rat ovary occurs in late pregnancy.
Anderson ST; Isa NN; Barclay JL; Waters MJ; Curlewis JD
Reproduction; 2009 Sep; 138(3):537-44. PubMed ID: 19502454
[TBL] [Abstract][Full Text] [Related]
12. Characterization of STAT5B phosphorylation correlating with expression of cytokine-inducible SH2-containing protein (CIS).
Cooper JC; Boustead JN; Yu CL
Cell Signal; 2006 Jun; 18(6):851-60. PubMed ID: 16125365
[TBL] [Abstract][Full Text] [Related]
13. Reconstruction of an active SOCS3-based E3 ubiquitin ligase complex in vitro: identification of the active components and JAK2 and gp130 as substrates.
Kershaw NJ; Laktyushin A; Nicola NA; Babon JJ
Growth Factors; 2014 Feb; 32(1):1-10. PubMed ID: 24438103
[TBL] [Abstract][Full Text] [Related]
14. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
15. Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II.
Chung AS; Guan YJ; Yuan ZL; Albina JE; Chin YE
Mol Cell Biol; 2005 Jun; 25(11):4716-26. PubMed ID: 15899873
[TBL] [Abstract][Full Text] [Related]
16. The many faces of the SOCS box.
Piessevaux J; Lavens D; Peelman F; Tavernier J
Cytokine Growth Factor Rev; 2008; 19(5-6):371-81. PubMed ID: 18948053
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I.
Fleenor D; Arumugam R; Freemark M
Horm Res; 2006; 66(3):101-10. PubMed ID: 16735796
[TBL] [Abstract][Full Text] [Related]
18. A complex interaction pattern of CIS and SOCS2 with the leptin receptor.
Lavens D; Montoye T; Piessevaux J; Zabeau L; Vandekerckhove J; Gevaert K; Becker W; Eyckerman S; Tavernier J
J Cell Sci; 2006 Jun; 119(Pt 11):2214-24. PubMed ID: 16684815
[TBL] [Abstract][Full Text] [Related]
19. Targeting Lyn tyrosine kinase through protein fusions encompassing motifs of Cbp (Csk-binding protein) and the SOCS box of SOCS1.
Whiting RJ; Payne CJ; Satiaputra J; Kucera N; Qiu TW; Irtegun S; Gunn NJ; Slavova-Azmanova NS; Mulhern TD; Ingley E
Biochem J; 2012 Mar; 442(3):611-20. PubMed ID: 22364282
[TBL] [Abstract][Full Text] [Related]
20. The C-terminus of CIS defines its interaction pattern.
Lavens D; Ulrichts P; Catteeuw D; Gevaert K; Vandekerckhove J; Peelman F; Eyckerman S; Tavernier J
Biochem J; 2007 Jan; 401(1):257-67. PubMed ID: 16961462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
